2008
DOI: 10.1038/gene.2008.66
|View full text |Cite
|
Sign up to set email alerts
|

Initial description of the human NLRP3 promoter

Abstract: Mutations in NLRP3 (CIAS1) are identified in a continuum of related inflammatory disorders, known as cryopyrinopathies since NLRP3 codes for the protein cryopyrin. Approximately 40% of patients with classic presentation lack mutations in the coding region of NLRP3 suggesting heterogeneity or epigenetic factors. Cryopyrin is a key regulator of proinflammatory cytokine release. Therefore, variations in the NLRP3 promoter sequence may have effects on disease state in patients with cryopyrinopathies and other infl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 25 publications
(24 reference statements)
0
26
0
2
Order By: Relevance
“…As cryopyrin is critical to the initial nucleation step in inflammasome activation [31], reduction of its levels could account for the diminished activity of the inflammasome. Such a mechanism would be in keeping with the proposition of how inflammasomes form and the recognition that a large proportion of patients with cryopyrin-associated periodic syndrome appear to suffer from the consequence of increased expression of the components of the inflammasome, rather than an innately more active inflammasome [32]. However, we have not established that the reduced levels of cryopyrin wholly account for the reduced activity of this inflammasome, and therefore, it cannot be excluded that PKR activity regulates the expression of alternative transcripts that control this response.…”
Section: Discussionmentioning
confidence: 89%
“…As cryopyrin is critical to the initial nucleation step in inflammasome activation [31], reduction of its levels could account for the diminished activity of the inflammasome. Such a mechanism would be in keeping with the proposition of how inflammasomes form and the recognition that a large proportion of patients with cryopyrin-associated periodic syndrome appear to suffer from the consequence of increased expression of the components of the inflammasome, rather than an innately more active inflammasome [32]. However, we have not established that the reduced levels of cryopyrin wholly account for the reduced activity of this inflammasome, and therefore, it cannot be excluded that PKR activity regulates the expression of alternative transcripts that control this response.…”
Section: Discussionmentioning
confidence: 89%
“…Several binding motifs were previously noticed for the proliferative and proinflammatory transcription factors, including SP1, c-MYB, AP-1, c-ETS (18), and recently, NF-B (25). However, the induction of NLRP3 by PXR was unlikely via these motifs because the PXR activation were known to inhibit NF-B and AP-1 both in the liver and ECs (7, 26) Instead, we found recurrent PXREs in the NLRP3 promoter and confirmed the PXR binding and activation, although the functionality of each individual motif was difficult to be dissected due to the multiplicity of the motifs.…”
Section: Discussionmentioning
confidence: 99%
“…Sequence variants in the promoter region were found in a portion of these mutation-negative patients, possibly leading to enhanced gene transcription [105]. In addition, a single nucleotide polymorphism in the 3 0 UTR of NLRP3 has been shown to be linked to disease [106].…”
Section: Stimuli Activating Nlrp3mentioning
confidence: 99%